REPORT ID 6828

Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2022

Publish Date
1-Nov-17
Pages
91
Format
Electronic (PDF)

This report studies the global Ophthalmic Therapeutics/Drug market, analyzes and researches the Ophthalmic Therapeutics/Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Novartis AG
    Allergan
    Santen Pharmaceutical Co., Ltd.
    Pfizer Inc.
    Merck & Co., Inc.
    Genentech, Inc.
    ...

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Ophthalmic Therapeutics/Drug can be split into
    Antiallergy
    Anti-VEGF agents
    Anti-inflammatory
    Antiglaucoma
    Others

Market segment by Application, Ophthalmic Therapeutics/Drug can be split into
    Dry Eye
    Allergies
    Glaucoma
    Inflammation/Infection
    Retinal Disorders
    Uveitis
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2022
1 Industry Overview of Ophthalmic Therapeutics/Drug
    1.1  Ophthalmic Therapeutics/Drug Market Overview
        1.1.1 Ophthalmic Therapeutics/Drug Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Ophthalmic Therapeutics/Drug Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Ophthalmic Therapeutics/Drug Market by Type
        1.3.1 Antiallergy
        1.3.2 Anti-VEGF agents
        1.3.3 Anti-inflammatory
        1.3.4 Antiglaucoma
        1.3.5 Others
    1.4 Ophthalmic Therapeutics/Drug Market by End Users/Application
        1.4.1 Dry Eye
        1.4.2 Allergies
        1.4.3 Glaucoma
        1.4.4 Inflammation/Infection
        1.4.5 Retinal Disorders
        1.4.6 Uveitis
        1.4.7 Others

2 Global Ophthalmic Therapeutics/Drug Competition Analysis by Players
    2.1 Ophthalmic Therapeutics/Drug Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Novartis AG
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Allergan
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Santen Pharmaceutical Co., Ltd.
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Pfizer Inc.
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Merck & Co., Inc.
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Genentech, Inc.
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
        3.6.5 Recent Developments

4 Global Ophthalmic Therapeutics/Drug Market Size by Type and Application (2012-2017)
    4.1 Global Ophthalmic Therapeutics/Drug Market Size by Type (2012-2017)
    4.2 Global Ophthalmic Therapeutics/Drug Market Size by Application (2012-2017)
    4.3 Potential Application of Ophthalmic Therapeutics/Drug in Future
    4.4 Top Consumer/End Users of Ophthalmic Therapeutics/Drug

5 United States Ophthalmic Therapeutics/Drug Development Status and Outlook
    5.1 United States Ophthalmic Therapeutics/Drug Market Size (2012-2017)
    5.2 United States Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

6 EU Ophthalmic Therapeutics/Drug Development Status and Outlook
    6.1 EU Ophthalmic Therapeutics/Drug Market Size (2012-2017)
    6.2 EU Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

7 Japan Ophthalmic Therapeutics/Drug Development Status and Outlook
    7.1 Japan Ophthalmic Therapeutics/Drug Market Size (2012-2017)
    7.2 Japan Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

8 China Ophthalmic Therapeutics/Drug Development Status and Outlook
    8.1 China Ophthalmic Therapeutics/Drug Market Size (2012-2017)
    8.2 China Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

9 India Ophthalmic Therapeutics/Drug Development Status and Outlook
    9.1 India Ophthalmic Therapeutics/Drug Market Size (2012-2017)
    9.2 India Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Ophthalmic Therapeutics/Drug Development Status and Outlook
    10.1 Southeast Asia Ophthalmic Therapeutics/Drug Market Size (2012-2017)
    10.2 Southeast Asia Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Ophthalmic Therapeutics/Drug Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
        11.1.2 EU Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
        11.1.4 China Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
        11.1.5 India Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
    11.2 Global Ophthalmic Therapeutics/Drug Market Size (Value) by Type (2017-2022)
    11.3 Global Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022)

12 Ophthalmic Therapeutics/Drug Market Dynamics
    12.1 Ophthalmic Therapeutics/Drug Market Opportunities
    12.2 Ophthalmic Therapeutics/Drug Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Ophthalmic Therapeutics/Drug Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Ophthalmic Therapeutics/Drug Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source